Clinical trial
Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis
NCT00004440 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis
- Lead sponsor
- FDA Office of Orphan Products Development
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 1996
- Completion date
- June 30, 1999
- Enrollment
- 75
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.